Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock 70kDa protein 8 (HSPA8), also known as HSC70, is a constitutively expressed member of the Hsp70 family that acts as a primary molecular chaperone in the cytoplasm and nucleus (UniProt: P11142). Unlike stress-induced heat shock proteins, HSPA8 is essential for cellular homeostasis, facilitating the folding of newly synthesized proteins and the refolding of misfolded ones. It plays a unique role in clathrin-mediated endocytosis by catalyzing the uncoating of clathrin from coated vesicles and is the central component of chaperone-mediated autophagy (CMA), directing specific proteins to the lysosome for degradation (PubMed: 25233119). In oncology, HSPA8 is frequently overexpressed, where it supports the stability of oncogenic drivers and protects cancer cells from proteotoxic stress (PubMed: 30107123). In autoimmune diseases like systemic lupus erythematosus, HSPA8 is involved in the processing and presentation of self-antigens, making it a target for the therapeutic peptide P140 (Lupuzor) (PubMed: 26109443). Therapeutic strategies targeting HSPA8 include small-molecule inhibitors of its ATPase activity and peptides that disrupt its interaction with co-chaperones or client proteins. However, because HSPA8 is ubiquitously expressed and vital for normal cell function, achieving a therapeutic window without significant off-target toxicity remains a major challenge in drug development.
Inhibition of the N-terminal ATPase domain to prevent ATP hydrolysis and subsequent substrate release, or modulation of chaperone-mediated autophagy (CMA) to alter lysosomal degradation of specific proteins (PubMed: 26109443, 30107123).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock 70kDa protein 8 (HSPA8).